All Stories

  1. Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy
  2. Kidney disease reprograms microbiome-host signaling to promote heart failure
  3. Secondary bile acid production by gut bacteria promotes Western diet-associated colorectal cancer
  4. Deactivation of ceramide de novo synthesis induces cerebral angiogenesis and microvascular remodeling post-ischemia/reperfusion in mice via mechanisms not predominated by extracellular vesicles
  5. Influence of amitriptyline therapy on T cell phenotype in chronic pain patients
  6. Targeting sphingolipid metabolism: inhibition of neutral sphingomyelinase 2 impairs coronaviral replication organelle formation
  7. Genome-wide identification of modulators of Chlamydia trachomatis parasitophorous vacuole stability highlights an important role for sphingolipid supply
  8. Amitriptyline inhibits Plasmodium development in infected red blood cells by modulating sphingolipid metabolism and glucose uptake
  9. Neisseria meningitidis regulates P-glycoprotein transporter activity in brain endothelial cells via sphingosine 1–phosphate receptor 1
  10. Immune cells in dorsal root ganglia are associated with pruritus in a mouse model of allergic contact dermatitis and co-culture study
  11. Chlamydia trachomatis exploits sphingolipid metabolic pathways during infection of phagocytes
  12. Development of an iPSC-derived immunocompetent skin model for identification of skin sensitizing substances
  13. Altered liver lipidome markedly overlaps with human plasma lipids at diabetes risk and reveals adipose-liver interaction
  14. Development and validation of an LC-MS/MS assay for quantification of fosfomycin in Mueller-Hinton broth for application in profiling antibacterial efficacy against clinical bacterial isolates
  15. Sphingosine kills Mycobacteria and suppresses mycobacterial lung infections
  16. Psychosomatic - psychotherapeutic treatment of stress-related disorders impacts the sphingolipid metabolism towards increased sphingosine and sphingosine-1-phosphate levels
  17. Circulating Extracellular Vesicles as Putative Mediators of Cardiovascular Disease in Paediatric Chronic Kidney Disease
  18. Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia
  19. Lebendzell‐Identifizierung von Inhibitoren des Lipid‐Transfer Proteins CERT Mithilfe von Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET)
  20. Live‐Cell Identification of Inhibitors of the Lipid Transfer Protein CERT Using Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET)
  21. The sphingosine kinase 2 inhibitors ABC294640 and K145 elevate (dihydro)sphingosine 1-phosphate levels in various cells
  22. Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension
  23. Transcriptomics pave the way into mechanisms of cobalt and nickel toxicity: Nrf2-mediated cellular responses in liver carcinoma cells
  24. Trifunctional sphingomyelin derivatives enable nanoscale resolution of sphingomyelin turnover in physiological and infection processes via expansion microscopy
  25. The Candida albicans quorum-sensing molecule farnesol alters sphingolipid metabolism in human monocyte-derived dendritic cells
  26. Dynamic changes in the proximitome of neutral sphingomyelinase-2 (nSMase2) in TNFα stimulated Jurkat cells
  27. Gut dysbiosis contributes to TMAO accumulation in CKD
  28. Caveolin-1 affects early mycobacterial infection and apoptosis in macrophages and mice
  29. Dissecting Acute Drug‐Induced Hepatotoxicity and Therapeutic Responses of Steatotic Liver Disease Using Primary Mouse Liver and Blood Cells in a Liver‐On‐A‐Chip Model
  30. Acid ceramidase expression reduces IFNγ secretion by mouse CD4+ T cells and is crucial for maintaining B-cell numbers in mice
  31. Degradation of hexosylceramides is required for timely corpse clearance via formation of cargo-containing phagolysosomal vesicles
  32. Fertilization by short-term stored sperm alters DNA methylation patterns at single-base resolution in common carp (Cyprinus carpio) embryos
  33. Formation of DNA Adducts by 1-Methoxy-3-indolylmethylalcohol, a Breakdown Product of a Glucosinolate, in the Mouse: Impact of the SULT1A1 Status—Wild-Type, Knockout or Humanised
  34. The Role of Neutral Sphingomyelinase-2 (NSM2) in the Control of Neutral Lipid Storage in T Cells
  35. Plant defensive responses to insect eggs are inducible by general egg-associated elicitors
  36. Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
  37. Sphingosine kinase 1/S1P receptor signaling axis is essential for cellular uptake of Neisseria meningitidis in brain endothelial cells
  38. Urinary Excretion of Mercapturic Acids of the Rodent Carcinogen Methyleugenol after a Single Meal of Basil Pesto: A Controlled Exposure Study in Humans
  39. Follicular Delivery of Caffeine from a Shampoo for Hair Retention
  40. Aging of common carp (Cyprinus carpio L.) sperm induced by short-term storage does not alter global DNA methylation and specific histone modifications in offspring
  41. Development of Comorbid Depression after Social Fear Conditioning in Mice and Its Effects on Brain Sphingolipid Metabolism
  42. New Therapeutic Options in Pulmonal Diseases: Sphingolipids and Modulation of Sphingolipid Metabolism
  43. Efficient skin interactions of graphene derivatives: challenge, opportunity or both?
  44. Sphingosine as a New Antifungal Agent against Candida and Aspergillus spp.
  45. Cell-intrinsic ceramides determine T cell function during melanoma progression
  46. Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
  47. The acid ceramidase/ceramide axis controls parasitemia in Plasmodium yoelii-infected mice by regulating erythropoiesis
  48. Cell-intrinsic ceramides determine T cell function during melanoma progression
  49. Biodegradable core-multishell nanocarrier: Topical tacrolimus delivery for treatment of dermatitis
  50. Stbd1-deficient mice display insulin resistance associated with enhanced hepatic ER-mitochondria contact
  51. Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma
  52. Acid sphingomyelinase deactivation post-ischemia promotes brain angiogenesis and remodeling by small extracellular vesicles
  53. Inflammation in Children with CKD Linked to Gut Dysbiosis and Metabolite Imbalance
  54. Synthesis and Characterization of Ceramide-Containing Liposomes as Membrane Models for Different T Cell Subpopulations
  55. Ceramide levels in blood plasma correlate with major depressive disorder severity and its neutralization abrogates depressive behavior in mice
  56. Antimicrobial effects of inhaled sphingosine against Pseudomonas aeruginosa in isolated ventilated and perfused pig lungs
  57. CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis
  58. Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma
  59. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming
  60. S1P Signalling Axis Is Necessary for Adiponectin-Directed Regulation of Electrophysiological Properties and Oxidative Metabolism in C2C12 Myotubes
  61. A versatile high-performance LC-MS/MS assay for the quantification of voriconazole and its N-oxide metabolite in small sample volumes of multiple human matrices for biomedical applications
  62. COVID-19 and its clinical severity are associated with alterations of plasma sphingolipids and enzyme activities of sphingomyelinase and ceramidase
  63. Mouse Liver Compensates Loss of Sgpl1 by Secretion of Sphingolipids into Blood and Bile
  64. Inhaled sphingosine has no adverse side effects in isolated ventilated and perfused pig lungs
  65. Sphingolipids: Effectors and Achilles Heals in Viral Infections?
  66. Nuclear Sphingosine-1-phosphate Lyase Generated ∆2-hexadecenal is A Regulator of HDAC Activity and Chromatin Remodeling in Lung Epithelial Cells
  67. Sphingosine 1-phosphate metabolism and insulin signaling
  68. Epigenetic DNA Methylation of EBI3 Modulates Human Interleukin-35 Formation via NFkB Signaling: A Promising Therapeutic Option in Ulcerative Colitis
  69. Central Acting Hsp10 Regulates Mitochondrial Function, Fatty Acid Metabolism, and Insulin Sensitivity in the Hypothalamus
  70. Inhibition of acid sphingomyelinase increases regulatory T cells in humans
  71. Click-correlative light and electron microscopy (click-AT-CLEM) for imaging and tracking azido-functionalized sphingolipids in bacteria
  72. Azidosphinganine enables metabolic labeling and detection of sphingolipid de novo synthesis
  73. Burn Injury Impairs Neutrophil Chemotaxis Through Increased Ceramide
  74. Acid Sphingomyelinase Impacts Canonical Transient Receptor Potential Channels 6 (TRPC6) Activity in Primary Neuronal Systems
  75. Liposomal FRET Assay Identifies Potent Drug‐Like Inhibitors of the Ceramide Transport Protein (CERT)
  76. Neutral Sphingomyelinase is an Affective Valence-Dependent Regulator of Learning and Memory
  77. Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers
  78. The Forebrain-Specific Overexpression of Acid Sphingomyelinase Induces Depressive-Like Symptoms in Mice
  79. A Role of Sphingosine in the Intracellular Survival of Neisseria gonorrhoeae
  80. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation
  81. Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease
  82. Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro
  83. S1P and Plasmalogen Derived Fatty Aldehydes in Cellular Signaling and Functions
  84. A photocaged inhibitor of acid sphingomyelinase
  85. Clinical Development of Sphingosine as Anti-Bacterial Drug: Inhalation of Sphingosine in Mini Pigs has no Adverse Side Effects
  86. Acid Sphingomyelinase Deficiency Ameliorates Farber Disease
  87. The Role of Chemoprophylactic Agents in Modulating Platelet Aggregability After Traumatic Brain Injury
  88. Role of Neutral Sphingomyelinase-2 (NSM 2) in the Control of T Cell Plasma Membrane Lipid Composition and Cholesterol Homeostasis
  89. Monitoring the Sphingolipid de novo Synthesis by Stable-Isotope Labeling and Liquid Chromatography-Mass Spectrometry
  90. Use of Acid Ceramidase and Sphingosine Kinase Inhibitors as Antiviral Compounds Against Measles Virus Infection of Lymphocytes in vitro
  91. Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells
  92. Acid sphingomyelinase – a regulator of canonical transient receptor potential channel 6 (TRPC6) activity
  93. Dermal Delivery of the High-Molecular-Weight Drug Tacrolimus by Means of Polyglycerol-Based Nanogels
  94. Sphingosine-coating of plastic surfaces prevents ventilator-associated pneumonia
  95. Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis
  96. Measles Virus Infection Fosters Dendritic Cell Motility in a 3D Environment to Enhance Transmission to Target Cells in the Respiratory Epithelium
  97. Identification of functional lipid metabolism biomarkers of brown adipose tissue aging
  98. Qualifying X-ray and Stimulated Raman Spectromicroscopy for Mapping Cutaneous Drug Penetration
  99. 1-Methoxy-3-indolylmethyl DNA adducts in six tissues, and blood protein adducts, in mice under pak choi diet: time course and persistence
  100. Core-multishell nanocarriers enhance drug penetration and reach keratinocytes and antigen-presenting cells in intact human skin
  101. Methionine restriction prevents onset of type 2 diabetes in NZO mice
  102. Fibroblast origin shapes tissue homeostasis, epidermal differentiation, and drug uptake
  103. Interleukin-22 protects intestinal stem cells against genotoxic stress
  104. Antidepressants regulate autophagy by targeting acid sphingomyelinase
  105. Ventilator-induced lung injury is aggravated by antibiotic mediated microbiota depletion in mice
  106. Pathological manifestations of Farber disease in a new mouse model
  107. Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor CDKN1A in colon cancer cells
  108. Antidepressants act by inducing autophagy controlled by sphingomyelin–ceramide
  109. Down‐regulation of acid sphingomyelinase and neutral sphingomyelinase‐2 inversely determines the cellular resistance to plasmalemmal injury by pore‐forming toxins
  110. Arsenic-containing hydrocarbons: effects on gene expression, epigenetics, and biotransformation in HepG2 cells
  111. Sphingosine Kinase 1 Regulates Inflammation and Contributes to Acute Lung Injury in Pneumococcal Pneumonia via the Sphingosine-1-Phosphate Receptor 2
  112. How Effective Is Tacrolimus in the Imiquimod-Induced Mouse Model of Psoriasis?
  113. Synthesis of poly(lactide-co-glycerol) as a biodegradable and biocompatible polymer with high loading capacity for dermal drug delivery
  114. Enhanced topical delivery of dexamethasone by β-cyclodextrin decorated thermoresponsive nanogels
  115. Selenium increases hepatic DNA methylation and modulates one-carbon metabolism in the liver of mice
  116. Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in NSCL Carcinoma.
  117. The sphingosine 1-phosphate breakdown product, (2 E )-hexadecenal, forms protein adducts and glutathione conjugates in vitro
  118. Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium
  119. Biocompatibility and characterization of polyglycerol-based thermoresponsive nanogels designed as novel drug-delivery systems and their intracellular localization in keratinocytes
  120. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity
  121. Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin - assessment by intradermal microdialysis and extraction from the different skin layers
  122. In SilicoPrediction of Human Sulfotransferase 1E1 Activity Guided by Pharmacophores from Molecular Dynamics Simulations
  123. Highly sensitive isotope-dilution liquid-chromatography–electrospray ionization–tandem-mass spectrometry approach to study the drug-mediated modulation of dopamine and serotonin levels in Caenorhabditis elegans
  124. Glucosinolates Are Mainly Absorbed Intact in Germfree and Human Microbiota-Associated Mice
  125. The glucosinolate metabolite 1-methoxy-3-indolylmethyl alcohol induces a gene expression profile in mouse liver similar to the expression signature caused by known genotoxic hepatocarcinogens
  126. Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans
  127. Simultaneous Detection of Multiple DNA Adducts in Human Lung Samples by Isotope-Dilution UPLC-MS/MS
  128. Method to Simultaneously Determine the Sphingosine 1-Phosphate Breakdown Product (2E)-Hexadecenal and Its Fatty Acid Derivatives Using Isotope-Dilution HPLC–Electrospray Ionization–Quadrupole/Time-of-Flight Mass Spectrometry
  129. A secondary metabolite of Brassicales, 1-methoxy-3-indolylmethyl glucosinolate, as well as its degradation product, 1-methoxy-3-indolylmethyl alcohol, forms DNA adducts in the mouse, but in varying tissues and cells
  130. Optimized enzymatic hydrolysis of DNA for LC–MS/MS analyses of adducts of 1-methoxy-3-indolylmethyl glucosinolate and methyleugenol
  131. Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samples
  132. Detection of DNA Adducts Originating from 1-Methoxy-3-indolylmethyl Glucosinolate Using Isotope-Dilution UPLC-ESI-MS/MS
  133. 1-Methoxy-3-indolylmethyl glucosinolate; a potent genotoxicant in bacterial and mammalian cells: Mechanisms of bioactivation